Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe someone in management should contact Ms. McCaughey.....
Phrantic, we are in complete agreement on the importance of news...so, when do you expect to hear about the initial beta test results? I'm hoping it's within the next few weeks. Thanks, lep.
Emergcy, at this stage everything depends on the hospital testing results followed by a capable and realistic business plan. TA is irrelevant.
Great news, Threw. The less time spent in hospital, the better. Best wishes for 100% recovery!
Hospital testing results + peer reviewed article + commercial apps + bioterror apps should put current sp in rearview mirror.
But you would admit that the video is a good summary of the HAI issue, right?
-$$ costs to patients, insurers, hospitals, government
-loss of human life 48K/yr.
-continued excessive use of antibiotics leading to more drug resistance bugs not to mention the high cost of the antibiotics.
So if AsepticSure turns out to be The Solution this video will be The Problem.
That is a terrific video-it is a good review of the economic and social burdens of HAI-all in 3+ minutes. Thanks for posting it!
Smeatz, a major "Thank You" from the shareholders!
Phrantic, can you tell us about this conversation? Thanks, lep
The space to be sterilized is sealed then treated; it is unsealed when O3 is below detectable EPA limits.
If the past is prologue then private insurers (third parties) will eventually adopt these Medicare guidelines.
Smeatz, by "our guys" I mean whoever maintains the MZEI website.
Smeatz, your post is really interesting...but since MZEI has a web site already couldn't our own people carry out the changes you propose? I guess that the missing link is Mr. M. telling our guys to bring about your suggestions, right??
The technology is designed so that when the treatment is done and the space is unsealed the resultant concentration of O3 is almost undetectable.
In reading the recent CEO message I was impressed by the company's ability to improve design and function of the prototype "on the run". To me that indicates a good engineering crew. I also see that we're planning to start hospital testing in both U.S. and Canada. Wouldn't it be something if major university hospitals were involved? Things are going to get very interesting this year.
Are the MM's waging war on our SP?
Dr. Pronovost is a great physician whose work centers on hand washing and sterile technique but does not deal at all with the filthy hospital environment. That's where AsepticSure comes in to play.
Do you have any idea how many bacteria reside on shower curtains, etc??
One form of PR which has not been seen yet is a peer reviewed scientific publication in a major infectious disease journal. I am 100% confident that such work is being prepared and equally confident that it will create a sensation when it appears. Hospitals are pigsties and every practicing physician knows this. A space cleaning technology like AsepticSure will be nothing less than revolutionary. Hang on to your shares, friends, the day of scientific vindication is coming.
Newbie2, go to msg. 7537 and read the NYT article attached. You should be impressed by several things:
1. There are hospital acquired infections for which no antibiotic cures exist.
2. The article is in the Business Section of the paper.
Think about it, read the article again, learn about AsepticSure on the company website and put your shares in a drawer somewhere. Good luck, lep
Thanks!
Any response from management??
SEE #7537.
If I were trying to drum up interest in MZEI I would offer the NYT article as the problem and AsepticSure as the solution. Combined with readily availble public information on the financial consequences of extra patient days due to HAI, this should make compelling reading, IMO.
Thanks on behalf of the shareholders on this board!
Articles like this one are free PR for our company-if properly utilized. Can you send EM and MS a copy? Thanks in advance, lep
http://www.nytimes.com/2010/02/27/business/27germ.html?ref=science
News of the superbug threat in today's NY Times. According to this article the only recourse is antibiotics. Conclusion: this company is TOTALLY under the radar. This is our problem and our huge opportunity.
Thanks, Spumoni. IMO, time is our ally.
Ben K's points are reasonable. And WhatIsValue and 17 yr. man also make intelligent comments. Does anyone doubt that attracting institutional support will be necessary in order for the pps to reach the dollars level? If so the company will have to submit to a financial and strategic X-ray from the big boys, at the very least because no fund manager or investment decision committee will be able to justify buying shares because they "read about" MZEI on iHub. In this sense WiV is 100% correct. I do think, however, that the preparations for MZEI's "coming out" party are being taken behind the scenes in a careful step by step manner. Having brought the company to this point and recognizing the bad prior history of MZEI ( the Groundell fiasco) I believe management is being exceptionally cautious and for this shareholders should be grateful.
The race will go to those who are patient and among those I count myself. The divisions on this board are about temperament and long term frustration tolerance. Just one final simple point: people yammer about how the current price "should" be in the dollars range. Really? Would anyone like to pay me $2.50 per share next week? No? Why not? Because it's not worth that now. So don't confuse current fantasies with future potential. We have a great foal here but it's not ready for this year's Preakness.
Is there a possibility of Canadian govt. grant $$ via CFGH??
There are mutual funds which promote socially responsible investments. MZEI should become known via its link to CFGH!
17yrman, you might be 100% correct-or Ed may have a couple of aces up his sleeve. I think they've presented their PR in a professional and somewhat understated manner. If people are skeptical and require news of sales contracts and royalties, so be it. I think they will find many receptive markets all over the world but right now- based on potential alone- the share price is reasonable. Who would pay $2.00/share today? Obviously, no one on this board. But we all think that in a year's time someone else will. So we have to wait.
The next step is to take AsepticSure into an actual hospital and demonstrate a drop in infection rates of patients.
The main thrust of the German paper is sterilization of surgical instruments.
The share price will rise when machines are sold and royalty agreements are confirmed, period. In this economic climate where all small investors are still licking their wounds, small company stocks will have to climb an Everest of skepticism. Until then all this yakking about resistance levels, etc. is just amateurish nonsense.
This company has been perfectly transparent about its science, financing and potential future prospects. Not that long ago the pps was under a penny. Why are people freaking? This will be a long and interesting story. Enjoy the ride!
First post of 2010: at a New Year's Eve party last night I met a very experienced ICU doc and told him about MZEI's space disinfection efforts aimed at hospital rooms. Response: Wow! especially when I mentioned log 6-7 killing of bacterial species. The future is bright.
Here are a few reasonable questions:
-will AsepticSure be applicable to community acquired MRSA, C. diff. etc? Currently we think of AS as a technology for closed space sterilization ( ICU, OR, e.g.).
-once AS sterilizes a space how long does it stay sterile?
-how will MZEI and partners handle the all important service component of this business?
-is there scientific evidence that pathogens can/cannot mutate to resist O3 oxidation? Bacteria have developed very intricate mechanisms for antibiotic resistance via mutation.
-does O3 have any effectiveness against TB, which has shown major antibiotic resistance in the last decade?
I look forward to learning more about MZEI's disease fighting potential. Very long and exceedingly strong in this corner!
Our beginning is promising. But bacterial decontamination has to translate into lower infection rates in hospitals=cost savings. This work will take time to carry out and them will have to be verified independently. If the share price is in the 1-2 dollar range next summer it will be a remarkable achievement.
So..the entire Pacific Rim for slightly more than 300,000 shares? Not bad, it seems. Someone is looking ahead to maximize shareholder value.
Please explain significance of consolidation as we move into Channel Two. Thanks!